Alibaba Health Information Technology Limited (HKG:0241)

Market Cap	99.73B +81.3%
Revenue (ttm)	36.09B +16.5%
Net Income	2.11B +60.0%
EPS	0.13 +51.8%
Shares Out	16.16B
PE Ratio	47.34
Forward PE	33.86
Dividend	n/a
Ex-Dividend Date	n/a

Volume	39,481,552
Average Volume	105,569,743
Open	6.06
Previous Close	6.17
Day's Range	6.00 - 6.16
52-Week Range	3.85 - 7.91
Beta	1.78
RSI	47.76
Earnings Date	Feb 25, 2026

About HKG:0241

Alibaba Health Information Technology Limited, an investment holding company, engages in the pharmaceutical direct sales, pharmaceutical e-commerce platform, and healthcare and digital services businesses in Mainland China and Hong Kong. The company offers a range of prescription and over-the-counter drugs, nutritional supplements, medical devices, contact lenses, healthcare food, adult and family planning products, and various other health-related products. It also provides medical and healthcare services, including medical checkups, medical c...

• Industry: Pharmaceutical Retailers
• Sector: Healthcare
• Founded: 1998
• Employees: 1,357
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 0241

Financial Performance

In fiscal year 2025, HKG:0241's revenue was 30.60 billion, an increase of 13.22% compared to the previous year's 27.03 billion. Earnings were 1.43 billion, an increase of 62.14%.

Financial numbers in CNY